IXJ vs. NOVO-B.CO
Compare and contrast key facts about iShares Global Healthcare ETF (IXJ) and Novo Nordisk A/S (NOVO-B.CO).
IXJ is a passively managed fund by iShares that tracks the performance of the S&P Global Healthcare Sector Index. It was launched on Nov 13, 2001.
Performance
IXJ vs. NOVO-B.CO - Performance Comparison
Loading graphics...
IXJ vs. NOVO-B.CO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IXJ iShares Global Healthcare ETF | -2.96% | 14.99% | 0.55% | 3.62% | -4.94% | 19.60% | 12.74% | 23.23% | 2.83% | 20.44% |
NOVO-B.CO Novo Nordisk A/S | -25.78% | -39.54% | -15.04% | 55.49% | 22.06% | 62.19% | 24.39% | 29.71% | -12.97% | 54.02% |
Different Trading Currencies
IXJ is traded in USD, while NOVO-B.CO is traded in DKK. To make them comparable, the NOVO-B.CO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, IXJ achieves a -2.96% return, which is significantly higher than NOVO-B.CO's -25.78% return. Over the past 10 years, IXJ has outperformed NOVO-B.CO with an annualized return of 8.51%, while NOVO-B.CO has yielded a comparatively lower 5.41% annualized return.
IXJ
- 1D
- 1.05%
- 1M
- -5.74%
- YTD
- -2.96%
- 6M
- 3.71%
- 1Y
- 6.94%
- 3Y*
- 5.79%
- 5Y*
- 5.55%
- 10Y*
- 8.51%
NOVO-B.CO
- 1D
- 2.84%
- 1M
- 2.36%
- YTD
- -25.78%
- 6M
- -34.10%
- 1Y
- -44.56%
- 3Y*
- -20.52%
- 5Y*
- 3.75%
- 10Y*
- 5.41%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IXJ vs. NOVO-B.CO — Risk / Return Rank
IXJ
NOVO-B.CO
IXJ vs. NOVO-B.CO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Global Healthcare ETF (IXJ) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IXJ | NOVO-B.CO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.40 | -0.79 | +1.19 |
Sortino ratioReturn per unit of downside risk | 0.68 | -0.93 | +1.61 |
Omega ratioGain probability vs. loss probability | 1.09 | 0.87 | +0.21 |
Calmar ratioReturn relative to maximum drawdown | 0.50 | -0.80 | +1.30 |
Martin ratioReturn relative to average drawdown | 1.37 | -1.39 | +2.76 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| IXJ | NOVO-B.CO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.40 | -0.79 | +1.19 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.40 | 0.10 | +0.30 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.55 | 0.16 | +0.38 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.43 | 0.43 | -0.01 |
Correlation
The correlation between IXJ and NOVO-B.CO is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
IXJ vs. NOVO-B.CO - Dividend Comparison
IXJ's dividend yield for the trailing twelve months is around 1.44%, less than NOVO-B.CO's 4.94% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IXJ iShares Global Healthcare ETF | 1.44% | 1.40% | 1.50% | 1.38% | 1.17% | 1.12% | 1.27% | 1.42% | 2.11% | 1.46% | 1.73% | 2.85% |
NOVO-B.CO Novo Nordisk A/S | 4.94% | 3.58% | 1.59% | 1.01% | 1.19% | 1.27% | 2.02% | 2.11% | 2.64% | 2.27% | 3.69% | 1.25% |
Drawdowns
IXJ vs. NOVO-B.CO - Drawdown Comparison
The maximum IXJ drawdown since its inception was -40.60%, smaller than the maximum NOVO-B.CO drawdown of -74.86%. Use the drawdown chart below to compare losses from any high point for IXJ and NOVO-B.CO.
Loading graphics...
Drawdown Indicators
| IXJ | NOVO-B.CO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.60% | -76.75% | +36.15% |
Max Drawdown (1Y)Largest decline over 1 year | -10.35% | -54.94% | +44.59% |
Max Drawdown (5Y)Largest decline over 5 years | -18.14% | -76.75% | +58.61% |
Max Drawdown (10Y)Largest decline over 10 years | -27.35% | -76.75% | +49.40% |
Current DrawdownCurrent decline from peak | -7.07% | -75.38% | +68.31% |
Average DrawdownAverage peak-to-trough decline | -6.92% | -15.80% | +8.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.78% | 32.14% | -28.36% |
Volatility
IXJ vs. NOVO-B.CO - Volatility Comparison
The current volatility for iShares Global Healthcare ETF (IXJ) is 5.11%, while Novo Nordisk A/S (NOVO-B.CO) has a volatility of 9.70%. This indicates that IXJ experiences smaller price fluctuations and is considered to be less risky than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| IXJ | NOVO-B.CO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.11% | 9.70% | -4.59% |
Volatility (6M)Calculated over the trailing 6-month period | 10.23% | 41.71% | -31.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.33% | 57.00% | -39.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.08% | 39.06% | -24.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.66% | 33.04% | -17.38% |